Literature DB >> 16452916

Low-dietary fiber intake as a risk factor for recurrent abdominal pain in children.

A Z Paulo1, O M S Amancio, M B de Morais, K M M D Tabacow.   

Abstract

OBJECTIVE: To evaluate dietary fiber intake in children with recurrent abdominal pain.
DESIGN: Cross-sectional study with control group.
SETTING: Outpatients of the Pediatric Gastroenterology public health clinic of the Darcy Vargas Children's Hospital, Brazil.
SUBJECTS: Forty-one patients with recurrent abdominal pain were evaluated and 41 children, as a control group.
INTERVENTIONS: Macronutrients and fiber intake evaluation by the Daily Food Intake method. Two tables of fiber composition in foods were used.
RESULTS: According to the Brazilian table the mean intake of fiber (g/day) by the children of the recurrent abdominal pain groups with chronic constipation or not, and the control group was, respectively, 18.2, 16.6 and 23.7 for total fiber (P=0.001), 7.5, 6.9 and 9.5 for soluble fiber (P=0.001) and 10.7, 9.7 and 14.1 for insoluble fiber (P=0.002). According to the AOAC table, the recurrent abdominal pain group with chronic constipation or not (10.6 and 9.9 g/day) also had lower intake of total fiber than the control group (13.4 g/day) (P=0.008). The intake of fiber was lower than the minimum recommended value (age+5 g) and statistically associated (P=0.021) with the recurrent abdominal pain group (78%) in comparison with the control one (51.2%). The odds ratio was 3.39 (95% CI, 1.18-9.95).
CONCLUSION: fiber intake below the minimum recommended value is a risk factor for recurrent abdominal pain in children.

Entities:  

Mesh:

Year:  2006        PMID: 16452916     DOI: 10.1038/sj.ejcn.1602386

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  10 in total

Review 1.  Dietary Carbohydrates and Childhood Functional Abdominal Pain.

Authors:  Bruno P Chumpitazi; Robert J Shulman
Journal:  Ann Nutr Metab       Date:  2016-06-30       Impact factor: 3.374

2.  Functional abdominal pain and irritable bowel syndrome in children and adolescents.

Authors:  Eric Chiou; Samuel Nurko
Journal:  Therapy       Date:  2011-05-01

Review 3.  Management of functional abdominal pain and irritable bowel syndrome in children and adolescents.

Authors:  Eric Chiou; Samuel Nurko
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-06       Impact factor: 3.869

Review 4.  Non-pharmacological management of abdominal pain-related functional gastrointestinal disorders in children.

Authors:  Siba Prosad Paul; Dharamveer Basude
Journal:  World J Pediatr       Date:  2016-06-30       Impact factor: 2.764

Review 5.  Dietary issues in recurrent abdominal pain.

Authors:  Robert J Shulman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-11       Impact factor: 2.839

Review 6.  Treatment options for functional gastrointestinal disorders: from empiric to complementary approaches.

Authors:  K Lynette Whitfield; Robert J Shulman
Journal:  Pediatr Ann       Date:  2009-05       Impact factor: 1.132

Review 7.  Update on Dietary Management of Childhood Functional Abdominal Pain Disorders.

Authors:  Bruno P Chumpitazi
Journal:  Gastroenterol Clin North Am       Date:  2018-09-28       Impact factor: 3.806

Review 8.  The Management of Paediatric Functional Abdominal Pain Disorders: Latest Evidence.

Authors:  Andrea Brusaferro; Edoardo Farinelli; Letizia Zenzeri; Rita Cozzali; Susanna Esposito
Journal:  Paediatr Drugs       Date:  2018-06       Impact factor: 3.022

Review 9.  A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified.

Authors:  Robyn Rexwinkel; Arine M Vlieger; Miguel Saps; Merit M Tabbers; Marc A Benninga
Journal:  Eur J Pediatr       Date:  2022-04-23       Impact factor: 3.860

10.  Overweight and obesity: Family factors, diet, and physical activity in school children from middle to high socioeconomic level in Cali, Colombia

Authors:  Adela Herrera; Consuelo Sarmiento
Journal:  Biomedica       Date:  2022-05-01       Impact factor: 1.173

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.